SEC Form 4/A · accession 0001019687-15-002507
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Steve Mitgang
Director
Period of report
May 15, 2015
Accepted (ET)
Jun 24, 2015 · 2:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 15, 2015 | P | 15,000 | $0.42 | A | 15,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Form 4 originally filed to report this transaction incorrectly reported that the reporting person acquired 5,000 shares. The correct number of shares acquired was 15,000. The 10,000 shares were omitted from the amount of securities beneficially owned as reported in Box 5 of Table I of the Form 4 filed by the reporting person on June 19, 2015.